<VariationArchive VariationID="1299301" VariationName="NM_000268.4(NF2):c.770_784del (p.Pro257_Ile261del)" VariationType="Deletion" Accession="VCV001299301" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2021-10-08" MostRecentSubmission="2021-10-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1163368" VariationID="1299301">
      <GeneList>
        <Gene Symbol="NF2" FullName="NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor" GeneID="4771" HGNC_ID="HGNC:7773" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29603556" stop="29698600" display_start="29603556" display_stop="29698600" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="29999544" stop="30094588" display_start="29999544" display_stop="30094588" Strand="+" />
          </Location>
          <OMIM>607379</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000268.4(NF2):c.770_784del (p.Pro257_Ile261del)</Name>
      <CanonicalSPDI>NC_000022.11:29661295:TCCCGTGGAATGAAATCC:TCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29661296" stop="29661310" display_start="29661296" display_stop="29661310" variantLength="15" positionVCF="29661295" referenceAlleleVCF="TTCCCGTGGAATGAAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="30057285" stop="30057299" display_start="30057285" display_stop="30057299" variantLength="15" positionVCF="30057284" referenceAlleleVCF="TTCCCGTGGAATGAAA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.30057288_30057302del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.30057288_30057302del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.29661299_29661313del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.29661299_29661313del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009057.1" sequenceAccession="NG_009057" sequenceVersion="1" change="g.62744_62758del">
            <Expression>NG_009057.1:g.62744_62758del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000268.4" sequenceAccession="NM_000268" sequenceVersion="4" change="c.770_784del" MANESelect="true">
            <Expression>NM_000268.4:c.770_784del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000259.1" sequenceAccession="NP_000259" sequenceVersion="1" change="p.Pro257_Ile261del">
            <Expression>NP_000259.1:p.Pro257_Ile261del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016418.5" sequenceAccession="NM_016418" sequenceVersion="5" change="c.770_784del">
            <Expression>NM_016418.5:c.770_784del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057502.2" sequenceAccession="NP_057502" sequenceVersion="2" change="p.Pro257_Ile261del">
            <Expression>NP_057502.2:p.Pro257_Ile261del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181825.3" sequenceAccession="NM_181825" sequenceVersion="3" change="c.770_784del">
            <Expression>NM_181825.3:c.770_784del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861546.1" sequenceAccession="NP_861546" sequenceVersion="1" change="p.Pro257_Ile261del">
            <Expression>NP_861546.1:p.Pro257_Ile261del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181828.3" sequenceAccession="NM_181828" sequenceVersion="3" change="c.644_658del">
            <Expression>NM_181828.3:c.644_658del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861966.1" sequenceAccession="NP_861966" sequenceVersion="1" change="p.Pro215_Ile219del">
            <Expression>NP_861966.1:p.Pro215_Ile219del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181829.3" sequenceAccession="NM_181829" sequenceVersion="3" change="c.647_661del">
            <Expression>NM_181829.3:c.647_661del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861967.1" sequenceAccession="NP_861967" sequenceVersion="1" change="p.Pro216_Ile220del">
            <Expression>NP_861967.1:p.Pro216_Ile220del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181830.3" sequenceAccession="NM_181830" sequenceVersion="3" change="c.521_535del">
            <Expression>NM_181830.3:c.521_535del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861968.1" sequenceAccession="NP_861968" sequenceVersion="1" change="p.Pro174_Ile178del">
            <Expression>NP_861968.1:p.Pro174_Ile178del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181831.3" sequenceAccession="NM_181831" sequenceVersion="3" change="c.521_535del">
            <Expression>NM_181831.3:c.521_535del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861969.1" sequenceAccession="NP_861969" sequenceVersion="1" change="p.Pro174_Ile178del">
            <Expression>NP_861969.1:p.Pro174_Ile178del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181832.3" sequenceAccession="NM_181832" sequenceVersion="3" change="c.770_784del">
            <Expression>NM_181832.3:c.770_784del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861970.1" sequenceAccession="NP_861970" sequenceVersion="1" change="p.Pro257_Ile261del">
            <Expression>NP_861970.1:p.Pro257_Ile261del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_156186.2" sequenceAccession="NR_156186" sequenceVersion="2" change="n.1252_1266del">
            <Expression>NR_156186.2:n.1252_1266del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181833.3" sequenceAccession="NM_181833" sequenceVersion="3" change="c.447+19014_447+19028del">
            <Expression>NM_181833.3:c.447+19014_447+19028del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_511" sequenceAccession="LRG_511">
            <Expression>LRG_511:g.62744_62758del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_511t2" sequenceAccession="LRG_511t2">
            <Expression>LRG_511t2:c.770_784del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_511p2" sequenceAccession="LRG_511p2" change="p.Pro257_Ile261del">
            <Expression>LRG_511p2:p.Pro257_Ile261del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000268.4" sequenceAccession="NM_000268" sequenceVersion="4" change="c.769_783del" MANESelect="true">
            <Expression>NM_000268.4:c.769_783del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2147010188" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="functionally_abnormal">
        <XRef ID="SO:0002218" DB="Sequence Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000268.4(NF2):c.770_784del (p.Pro257_Ile261del) AND Neurofibromatosis, type 2" Accession="RCV001725924" Version="2">
        <ClassifiedConditionList TraitSetID="840">
          <ClassifiedCondition DB="MedGen" ID="C0027832">Neurofibromatosis, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-10-08" MostRecentSubmission="2021-10-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="840" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3089" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NF 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurofibromatosis central type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acoustic schwannomas bilateral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bilateral acoustic neurofibromatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acoustic neurinoma bilateral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurofibromatosis type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neurofibromatosis, type 2</ElementValue>
                <XRef ID="Neurofibromatosis+type+2/5175" DB="Genetic Alliance" />
                <XRef ID="92503002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCHWANNOMATOSIS, VESTIBULAR</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BANF</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SWNV</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ACN</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000552306" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552305" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514608" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000335548" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552308" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576339" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000335543" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511190" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528652" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551653" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521547" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510681" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551659" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569525" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7193" />
                <XRef ID="7193" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Neurofibromatosis 2 (NF2) is characterized by bilateral vestibular schwannomas with associated symptoms of tinnitus, hearing loss, and balance dysfunction. The average age of onset is 18 to 24 years. Almost all affected individuals develop bilateral vestibular schwannomas by age 30 years. Affected individuals may also develop schwannomas of other cranial and peripheral nerves, meningiomas, ependymomas, and, very rarely, astrocytomas. Because NF2 is considered an adult-onset disease, it may be underrecognized in children, in whom skin tumors and ocular findings (retinal hamartoma, thickened optic nerves, cortical wedge cataracts, third cranial nerve palsy) may be the first manifestations. Mononeuropathy that occurs in childhood is an increasingly recognized finding; it frequently presents as a persistent facial palsy or hand/foot drop.</Attribute>
                <XRef ID="NBK1201" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301380</ID>
                <ID Source="BookShelf">NBK1201</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2020">
                <ID Source="PubMed">32602153</ID>
              </Citation>
              <XRef ID="637" DB="Orphanet" />
              <XRef ID="C0027832" DB="MedGen" />
              <XRef ID="MONDO:0007039" DB="MONDO" />
              <XRef Type="MIM" ID="101000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3851959" SubmissionDate="2021-09-28" DateLastUpdated="2021-10-08" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey="c.769_783del" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001963621" DateUpdated="2021-10-08" DateCreated="2021-10-08" Type="SCV" Version="1" SubmitterName="Cell and Gene Engineering Laboratory, Zhejiang University" OrgID="508134" OrganizationCategory="laboratory" OrgAbbreviation="CGEL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Loss of heterozygosity</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <GeographicOrigin>China</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <Description>Genomic DNA was isolated from the whole blood of participants using a TaKaRa Blood Genome DNA Extraction Kit (TaKaRa Biotechnology). 18 pairs of primers for PCR-amplifying exons and their flanking sequences were used for this analysis.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">c.769_783del</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2012-05-01" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002858" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0100008" />
              </Trait>
              <Comment>The 13-year-old proband (Ⅳ-3), whole bumps on the waist were found 9 years ago, was diagnosed with a neurofibromatosis type 2 associated neurilemmoma. The sagittal T1-weighted contrast-enhanced MRI of lumbar spine with revealed an iso hyperintense lesions at both L4-5 and L2-3 levels. The abdominal T1-weighted contrast-enhanced MRI also showed the left subcutaneous mass of the lumbar region. The hard bumps were about 3 × 4 cm at that time and they presented with clear boundaries</Comment>
            </TraitSet>
            <Comment>In this Chinese family we found two affected patients carried the c.769_783del in NF2. This c.769_783del may be involved in neurofibromatosis type 2 resulting in the skipping of exon 8. We further analyzed the presence of the 15 bp deletion in subjects by PCR-PAGE analysis, since the heterozygous 15 bp deletion resulted in two different sizes of PCR product. Our results demonstrated this variant can inhibit Hippo signaling pathway, affect cell cycle process, and promote the growth of both meningioma cells in vitro and subcutaneous tumors in vivo.</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NF2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000268.4:exon 8</GeneLocation>
          </Location>
          <FunctionalConsequence Value="functionally_abnormal">
            <XRef DB="Sequence Ontology" ID="SO:0002218" URL="http://www.sequenceontology.org/browser/current_svn/term/SO:0002218" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000268.4:c.769_783del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="101000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10436345</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3851959" TraitType="Disease" MappingType="XRef" MappingValue="101000" MappingRef="OMIM">
        <MedGen CUI="C0027832" Name="Neurofibromatosis, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3851959" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002858" MappingRef="HP">
        <MedGen CUI="C0025286" Name="Meningioma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3851959" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100008" MappingRef="HP">
        <MedGen CUI="C0027809" Name="Schwannoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

